Dupilumab Effect on Lung Function in Patients with Uncontrolled, Moderate-to-Severe Asthma with an Allergic Phenotype

被引：0
|
作者：
Castro, M. [1 ]
Corren, J. [2 ,3 ]
Casale, T. B.
Quirce, S. [4 ]
Rice, M. S. [5 ]
Deniz, Y. [6 ]
Rowe, P. [5 ]
Amin, N. [6 ]
Teper, A. [5 ]
机构：
[1] Washington Univ, Sch Med, St Louis, MO 14263 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90024 USA
[3] Univ S Florida, Tampa, FL 33620 USA
[4] Hosp La Paz Inst Hlth Res Idipaz, Madrid, Spain
[5] Sanofi, Paris, France
[6] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
来源：
PNEUMOLOGIE | 2020年 / 74卷
关键词：
D O I：
10.1055/s-0039-3403258
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P100
引用
收藏
页码：S89 / S89
页数：1
相关论文
共 50 条
  • [41] Dupilumab Induces Clinical Remission in Patients With Uncontrolled, Moderate-to-Severe, Type 2 Inflammatory Asthma
    Pavord, I. D.
    Israel, E.
    Szefler, S. J.
    Brusselle, G.
    Rabe, K. F.
    Chen, Z.
    Altincatal, A.
    Radwan, A.
    Pandit-Abid, N.
    Amin, N.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y. M.
    Khan, A.
    Lederer, D. J.
    Zhang, Y.
    Busse, W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [42] Dupilumab Treatment Leads to Clinical Asthma Remission in Patients With Uncontrolled Moderate-to-Severe Asthma With Type 2 Inflammation
    Pavord, Ian
    Busse, William
    Israel, Elliot
    Szefler, Stanley
    Chen, Zhen
    Daizadeh, Nadia
    Lederer, David
    Mannent, Leda
    Amin, Nikhil
    Laws, Elizabeth
    Ruddy, Marcella
    Rowe, Paul
    Deniz, Yamo
    Khan, Asif
    Zhang, Yi
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB4 - AB4
  • [43] Dupilumab for children with uncontrolled moderate or severe asthma
    Krandick, Guido
    MONATSSCHRIFT KINDERHEILKUNDE, 2022, 170 (03) : 196 - 197
  • [44] Dupilumab improves lung function and reduces severe exacerbations in uncontrolled persistent asthma patients with ongoing allergic rhinitis
    Weinstein, Steven
    Staudinger, Heribert
    Guillonneau, Sophie
    Taniou, Christine
    Eckert, Laurent
    Joish, Vijay
    Maroni, Jaman
    Rowe, Paul
    Amin, Nikhil
    Pirozzi, Gianluca
    Graham, Neil
    Teper, Ariel
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [45] Dupilumab treatment induces clinical remission in patients with uncontrolled, moderate-to-severe, type 2 inflammatory asthma
    Pavord, I.
    Pandit-Abid, N.
    Israel, E.
    Szefler, S.
    Brusselle, G.
    Rabe, K.
    Chen, Z.
    Altincatal, A.
    Amin, N.
    Khan, A.
    Lederer, D. H.
    Zhang, Y.
    Rowe, P. J.
    Deniz, Y.
    Amr, R.
    Jacob-Nara, J. A.
    Busse, W. W.
    ALLERGY, 2023, 78 : 206 - 207
  • [46] Dupilumab Efficacy in Patients with Uncontrolled Moderate-to-Severe Type 2 Asthma Regardless of Perennial Aeroallergen Sensitization
    Corren, Jonathan
    Jackson, David J.
    Casale, Thomas B.
    Borish, Larry
    Rabe, Klaus F.
    Busse, William W.
    Maspero, Jorge F.
    Jackson, Daniel J.
    Daizadeh, Nadia
    Altincatal, Arman
    Radwan, Amr
    Khodzhayev, Angela
    Djandji, Michel
    Jacob-Nara, Juby A.
    Rowe, Paul J.
    Deniz, Yamo
    JOURNAL OF ASTHMA AND ALLERGY, 2023, 16 : 249 - 260
  • [47] Dupilumab reduces severe exacerbations in patients with uncontrolled, moderate-to-severe allergic (atopic) asthma regardless of presence of perennial aeroallergen-specific IgE: LIBERTY ASTHMA QUEST
    Corren, J.
    Jackson, D. J.
    Casale, T. B.
    Daizadeh, N.
    Djandji, M.
    O'Riordan, T.
    Ortiz, B.
    Rowe, P.
    Deniz, Y.
    ALLERGY, 2020, 75 : 39 - 40
  • [48] DUPILUMAB REDUCES EXACERBATIONS AND IMPROVES LUNG FUNCTION IN UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA PATIENTS REGARDLESS OF PRIOR EXACERBATION HISTORY IN THE PHASE 3 LIBERTY ASTHMA QUEST STUDY
    Pavord, I.
    Ford, L. B.
    Corren, J.
    Kuna, P.
    Dong, Q.
    Staudinger, H.
    Maroni, J.
    Rowe, P.
    Rout, R.
    Amin, N.
    Akinlade, B.
    Graham, N. M. H.
    Teper, A.
    THORAX, 2018, 73 : A121 - A122
  • [49] Dupilumab Efficacy in Uncontrolled, Moderate-to-Severe Asthma with Self-Reported Chronic Rhinosinusitis
    Maspero, Jorge F.
    Katelaris, Constance H.
    Busse, William W.
    Castro, Mario
    Corren, Jonathan
    Chipps, Bradley E.
    Peters, Anju T.
    Pavord, Ian D.
    Ford, Linda B.
    Sher, Lawrence
    Rabe, Klaus F.
    Rice, Megan S.
    Rowe, Paul
    Lu, Yufang
    Harel, Sivan
    Jagerschmidt, Alexandre
    Khan, Asif H.
    Kamat, Siddhesh
    Pirozzi, Gianluca
    Amin, Nikhil
    Ruddy, Marcella
    Graham, Neil M. H.
    Mannent, Leda P.
    Teper, Ariel
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (02): : 527 - +
  • [50] Dupilumab Efficacy in Children with Uncontrolled, Moderate-to-severe Type 2 Asthma, with and Without Evidence of Allergic Asthma in the VOYAGE Phase 3 Study
    Papadopoulos, Nikolaos G.
    Szefler, Stanley J.
    Bacharier, Leonard B.
    Maspero, Jorge F.
    Domingo, Christian
    Daizadeh, Nadia
    Lederer, David J.
    Hardin, Megan
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Gall, Rebecca
    Ortiz, Benjamin
    Djandji, Michel
    Rowe, Paul J.
    PEDIATRICS, 2022, 149 (01)
12345